Lessons from Kawasaki disease: All brands of IVIG are not equal

Journal of Pediatrics

Volumn 148, Issue 1, 2006, Pages 7-8

  Stiehm, E Richard ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACID; IMMUNOGLOBULIN; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; INTRAGLOBIN; PEPSIN A; PLASMIN; PROPIOLACTONE; VENOGLOBIN;

CHILD; COMPLEMENT ACTIVATION; COMPLEMENT FIXATION; CORONARY ARTERY ANEURYSM; CYTOTOXICITY; DRUG EFFECT; DRUG MEGADOSE; EDITORIAL; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; MAJOR CLINICAL STUDY; MUCOCUTANEOUS LYMPH NODE SYNDROME; PREVALENCE; PRIORITY JOURNAL;

EID: 30744470144     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2005.09.019     Document Type: Editorial

References (15)

1. J.W. Newburger, M. Takahashi, M.A. Gerber, M.H. Gewitz, L.Y. Tani, and J.C. Burns Diagnosis, treatment and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association Pediatrics 114 2004 1708 1733
2. M.-H. Tsai, Y.-C. Huang, M.-H. Yen, C.-C. Li, C.-H. Chiu, and P.-Y. Lin Clinical responses of patients with Kawasaki to different brands of intravenous immunoglobulin J Pediatrics 148 2006 38 43
3. E.R. Stiehm The B-lymphocyte system: Clinical immunology E.R. Stiehm H.R. Ochs J.A. Winkelstein Immunologic disorders in infants and children 4th ed. 2004 Elsevier/Saunders Philadelphia 85 108
4. H. Nielsen Immunoglobulin preparations for intravenous administration. A review of their biologic activities and comparison of various preparation methods Allergy 49 1994 59 73
5. F. Skvaril, and A. Gardi Differences among available immunoglobulin preparations for intravenous use Pediatr Infect Dis J 7 Suppl 1988 S43 S48
6. T.W. Jungi, M. Santer, P.G. Lerch, and S. Barandun Effect of various treatments of gamma-globulin (IgG) for achieving intravenous tolerance of the capacity to interact with human monocyte Fc receptors Vox Sang 51 1986 18 26
7. S. Takei, Y.K. Arora, and S.M. Walker Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens J Clin Invest 91 1993 602 607
8. M. Takahashi The endothelium in Kawasaki disease: the next frontier J Pediatr 133 1988 177 179
9. M. Iwata, T. Shimozato, H. Tokiwa, and E. Tsubura Antipyretic activity of a human immunoglobulin preparation for intravenous use in an experimental model of fever in rabbits Infect Immunity 55 1987 547 554
10. T. Ichiyama, Y. Ueno, M. Hasegawa, A. Niimi, T. Matsubara, and S. Furukawa Intravenous immunoglobulin inhibits NF- kappa B activation and affects Fc-gamma receptor expression in monocytes/macrophages Naunyn Schmiedebergs Arch Pharmacol 369 2004 428 433
11. R.W. Finberg, J.W. Newburger, M.A. Mikati, A.H. Heller, and J.C. Burns Effect of high doses of intravenously administered immune globulin on natural cell activity in peripheral blood J Pediatr 120 1992 376 380
12. E.A. Rosenfeld, S.T. Shulman, K.E. Corydon, W. Mason, M. Takahashi, and C. Kuroda Comparative safety and efficacy of two immune globulin products in Kawasaki disease J Pediatr 126 1995 1000 1003
13. S. Shah, and M. Vervan Use of IV immune globulin and occurrence of associated acute renal failure and thrombosis Am J Health-Syst Pharm 62 2005 720 725
14. D. Paran, Y. Herishanu, O. Elkayam, L. Shopin, and R. Ben-Ami Venous and arterial thrombosis following administration of intravenous immunoglobulins Blood Coagul Fibrinolysis 16 2005 313 318
15. E.A. Sekul, E.J. Cupler, and M.C. Dalakas Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors Ann Intern Med 121 1994 259 262